- Title
- A randomized Phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato ® alprazolam for rapid seizure termination
- Creators
- Jacqueline French - NYU Langone HealthVictor Biton - Arkansas CardiologyHina Dave - The University of Texas Southwestern Medical CenterKamil Detyniecki - University of MiamiMichael A. Gelfand - University of PennsylvaniaHui Gong - Rancho Los Amigos National Rehabilitation CenterKore Liow - Hawaii Pacific UniversityTerence J. O’Brien - Monash UniversityAhmed Sadek - Product Innovation and Engineering (United States, Saint James) - LLCBree DiVentura - Epilepsy Study ConsortiumBrittany Reich - Engage Therapeutics, Inc., Summit, NJ, USA.Jouko Isojarvi - Engage Therapeutics, Inc., Summit, NJ, USA.
- Publication Details
- Epilepsia (Copenhagen), Vol.64(2), pp.374-385
- Academic Unit
- UMMG Dept of Neurology - Epilepsy Div; Miller School of Medicine; UMMG Department of Neurology
- Language
- English
- Resource Type
- Journal article
- PMID
- 36268811
- Record Identifier
- 991031785542802976
Journal article
A randomized Phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato ® alprazolam for rapid seizure termination
Epilepsia (Copenhagen), Vol.64(2), pp.374-385
2023-02
PMID: 36268811
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.222 Epilepsy & Seizures
- 1.222.143 Epilepsy
- Web Of Science research areas
- Clinical Neurology
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites